SEARCH

SEARCH BY CITATION

References

  • 1
    Forbes GM, Glaser ME, Cullen DJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 25860.
  • 2
    Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 7058.
  • 3
    Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 15914.
  • 4
    Hiyama T, Haruma K, Kitadai Y, et al. Eradication therapy of Helicobacter pylori for low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Exp Oncol 2000; 22: 7881.
  • 5
    Wotherspoon AC, Doglioni C, Diss Tc, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 5757.
  • 6
    Sasaki A, Haruma K, Kamada T, et al. Eradication of Helicobacter pylori leads to a long-term symptomatic benefit in patients with non-ulcer dyspepsia. Gut 2000; 47(Suppl. 1): A101 (Abstract).
  • 7
    Sasaki A, Kitadai Y, Ito M, et al. Helicobacter pylori infection influences tumor growth of human gastric carcinomas. Scand J Gastroenterol 2003; 38: 1538.
  • 8
    Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 63942.
  • 9
    Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 10
    Ito M, Haruma K, Kamada T, et al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 144956.
  • 11
    Labenz J, Blum AL, Bayerdorffer E, et al . Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 14427.
  • 12
    Hamada H, Haruma K, Mihara M, et al. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14: 72935.
  • 13
    Palmer ED. The hiatus hernia–oesophagitis–esophageal stricture complex. Twenty-year prospective study. Am J Med 1968; 44: 56679.
  • 14
    Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 82531.
  • 15
    Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 5103.
  • 16
    Bremner CG, Lynch VP, Ellis FH Jr. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970; 68: 20916.
  • 17
    Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 8592.
  • 18
    Chen X, Haruma K, Kamada T, et al. A low 13C-urea breath test value is associated with increased risk of gastric cancer. J Gastroenterol 2001; 36: 6015.
  • 19
    Shi G, Bruley des Varannes S, et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 45764.
  • 20
    Manabe N, Yoshihara M, Sasaki A, et al. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol 2002; 17: 94954.
  • 21
    Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroerterol 1999; 231(Suppl.): 4854.
  • 22
    Schutze K, Hentschel E, Dragosics B, et al. Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses. Gut 1995; 36: 8313.
  • 23
    Sipponen P, Hyvarinen H, Siurala M. H. pylori corpus gastritis-relation to acid output. J Physiol Pharmacol 1996; 47: 1519.
  • 24
    Haruma K, Mihara M, Okamoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 15562.
  • 25
    Yasunaga Y, Shinomura Y, Kanayama S, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 15714.
  • 26
    Gutierrez O, Melo M, Segura AM, et al. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 6648.
  • 27
    Tucci A, Biasco G, Paparo GF. Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis. N Engl J Med 1997; 336: 9578.
  • 28
    El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic acid hyposecretion. Gastroenterology 1997; 113: 1524.
  • 29
    Iijima K, Ohara S, Sekine H, et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: 206.
  • 30
    Moss SF, Calam J. Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. Gut 1993; 34: 88892.
  • 31
    El-Omar EM, Penman ID, Ardill JE, et al. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 68191.
  • 32
    Wang M, Furuta T, Takashima M, et al. Relation between interleukin-1 beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol 1999; 34(Suppl. 11): S107.
  • 33
    Furuta T, El-Omar EM, Xioa F, et al. Interleukin-1 beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123: 92105.